Life in the Balance: Perspectives on Stem Cell Research

Article

David Gollaher, president and CEO of California Healthcare Institute, discusses the tensions between stem cell research, ethics, and politics.

David Gollaher, president and CEO of California Healthcare Institute, discusses the tensions between stem cell research, ethics, and politics in America that are impeding the progress of developing promising cures.

During the disucssion, Gollaher said, "Every once in awhile in the history of science, there is what you might think of as a cross-over problem, which is something which has been important to scientific discovery and to the advance of science, crosses over into the realm of popular culture and politics. And this has happened just over the past several years with stem cells. Oddly enough, we find in elections going back to 2002, politicians talking about their policy or their attitudes with respect to stem cell science."

Source:

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
Veeral Sheth, MD: Assessment of EYP-1901 Supplemental Injection Use in Wet AMD | Image Credit: University Retina
© 2024 MJH Life Sciences

All rights reserved.